Sign Up to like & get
recommendations!
0
Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms26010318
Abstract: Aggressive variant prostate cancer (AVPC) is characterized by a molecular signature involving combined defects in TP53, RB1, and/or PTEN (AVPC-TSGs), identifiable through immunohistochemistry or genomic analysis. The reported prevalence of AVPC-TSG alterations varies widely, reflecting…
read more here.
Keywords:
cancer;
avpc tsg;
prostate cancer;
aggressive variant ... See more keywords